Home › Funds › Venrock Adviser, LLC › SRZN

Venrock Adviser, LLC position in SRZN

SURROZEN INC · Health Care

Venrock Adviser, LLC reported holding 632,931 shares of SRZN (SURROZEN INC) in its Q2 2026 13F filing — a position valued at US$16.4M, representing 0.50% of its reported portfolio and ranking #28 among its reported holdings. Venrock Adviser, LLC has disclosed SRZN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)632.93K sh
Reported value held$16.42M
Portfolio Weight0.50%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's SRZN position evolved

Venrock Adviser, LLC first disclosed a stake in SRZN in Q1 2025 at 632,931 shares (US$7.4M). The position peaked in Q1 2026 at 632,931 shares, worth US$18.4M. Across 6 filings, Venrock Adviser, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 632,931 shares valued at US$16.4M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 632.93K $7.38M New
Q2 2025 632.93K $5.66M Hold
Q3 2025 632.93K $8.16M Hold
Q4 2025 632.93K $14.30M Hold
Q1 2026 632.93K $18.44M Hold
Q2 2026 632.93K $16.42M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SRZN and 13F data

SRZN (SURROZEN INC) is a Health Care company. 51 other funds we track also report a position in SRZN — the largest reported positions include Column Group LLC (US$49.7M), TCG Crossover Management, LLC (US$38.2M), Boxer Capital Management, LLC (US$27.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRZN

All SRZN fund holders →

FAQ

How long has Venrock Adviser, LLC held SRZN?

Venrock Adviser, LLC has disclosed SRZN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Venrock Adviser, LLC's current position in SRZN?

As of Q2 2026, Venrock Adviser, LLC holds 632.93K shares of SRZN (SURROZEN INC), valued at $16.42M, representing 0.50% of its reported portfolio and ranking #28.

Has Venrock Adviser, LLC been buying or selling SRZN?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in SRZN. The position peaked in Q1 2026 at 632.93K shares.

Which other funds hold SRZN?

Other major institutional holders of SRZN include Column Group LLC, TCG Crossover Management, LLC, Boxer Capital Management, LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.